Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028856

Chief Legal Officer gave up 1,974 shares (to pay taxes)

  • Chief Legal Officer acquired 6,933 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-07 Exercise or conversion : show line 1 in the form +6,933 94,610 D
2018-05-07 Shares withheld for taxes : show line 2 in the form −1,974 $18.10 $35,729 92,636 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-07 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,933 5,200 D
Loading xslF345X03/doc4.xml…